Evofem Biosciences to Report Fourth Quarter and Year-End 2021 Results and Provide Corporate Update on Thursday, March 3, 2022

February 17, 2022

Biotechnology

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 21, 2025
Rani Therapeutics Announces Research Agreement with Chugai

May 19, 2025
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn® for ALS

May 19, 2025
Ocugen Provides Business Update with First Quarter 2025 Financial Results

May 9, 2025